• Outlook Therapeutics' (OTLK) Buy Rating Reaffirmed at HC Wainwright

    Source: Buzz FX / 17 Jan 2025 08:16:16   America/New_York


    Outlook Therapeutics' (OTLK) Buy Rating Reaffirmed at HC Wainwright Written by MarketBeat January 17, 2025 Share Link copied to clipboard. Outlook Therapeutics ( NASDAQ:OTLK - Get Free Report ) 's stock had its "buy" rating reiterated by st
    Read more...
Share on,